Surface Oncology
AcquiredCambridge, United States · Founded 2014
- Headquarters
- Cambridge, Massachusetts
- Founded
- 2014
- Business Model
- B2B
- Website
- surfaceoncology.com
About
Focused on developing novel oncology-focused antibody therapeutics against series of targets that modulate elements at the boundary of the innate and adaptive immune systems
Summary
Surface Oncology is a Biotech company based in Cambridge, United States, founded in 2014.
Similar Companies
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...
Develops Gene Writing technology and non-viral delivery to create in vivo genetic medicines for m...
San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.